Peptide biohacking for antiaging: what TikTok gets wrong

What did @ravyn.autumn actually say?

She returned to a CJC-1295 and ipamorelin stack after a four-week break and says she's seeing "glute growth that I've never seen before" within two weeks. She links the improved results to lower stress levels compared to the previous six months, and credits selank for helping manage anxiety. She recommends the combo to anyone wanting to "see your muscles, your physique, but better."

To her credit, she frames most of this as personal experience rather than medical advice. She connects stress hormones to gym performance, which is actually a reasonable point. The problem is the attribution: she can't isolate which variable, the cycling off, the stress reduction, the mindset shift, or just consistent training, drove her results. She doesn't claim to.

Does the science back this up?

Partially, but the evidence is thinner than TikTok peptide culture implies. CJC-1295 is a growth hormone releasing hormone (GHRH) analog. Ipamorelin is a ghrelin mimetic that acts as a growth hormone secretagogue. Together they stimulate pulsatile GH release, which can increase IGF-1, support lean mass, and aid recovery. That mechanism is real.

The catch: most human trials are small, short, and funded by parties with commercial interest. A 2006 study by Jetté et al. in Growth Hormone and IGF Research showed CJC-1295 raised GH and IGF-1 levels in healthy adults, but muscle hypertrophy outcomes were not measured. Ipamorelin's human data is similarly sparse. The pop-science claim that these peptides cause visible, measurable glute growth in two weeks is not supported by any controlled trial. Two weeks is also a notably short window for skeletal muscle hypertrophy, which typically requires 6 to 12 weeks of consistent stimulus to show measurable change on imaging.

What did they get wrong (or right)?

Right: the stress-cortisol-muscle connection is legitimate. Chronic psychological stress elevates cortisol, which is catabolic and blunts anabolic signaling. Research by Stults-Kolehmainen and Sinha (2014, Sports Medicine) confirmed that high life stress impairs training adaptations. If her cortisol was suppressed after the stressful period ended, that alone could explain better gym results, no peptides required.

Wrong: she says "Epimoralin" throughout, which appears to be ipamorelin mispronounced or a branding variant name. Minor, but worth noting since viewers searching for "epimoralin" may find mislabeled or unverified products.

Questionable: recommending a specific peptide stack to her audience without any discussion of individual GH status, contraindications, or the fact that these compounds are not FDA-approved for performance use. Encouraging followers to "add CJC and Epimoralin into your stack" is a blanket recommendation that skips the part where a clinician evaluates whether GH stimulation is even appropriate for a given person.

• She correctly links stress reduction to better training response
• She does not make explicit disease treatment claims
• She does not discuss sourcing, dosing, injection safety, or screening, which matters

What should you actually know?

CJC-1295 and ipamorelin are research peptides. In the US, they are not FDA-approved for aesthetic or performance use. They are available through compounding pharmacies for specific clinical indications under a provider's supervision, but that is different from adding them to a "stack" based on a TikTok recommendation.

If you're considering these peptides, the actual checklist looks like this:

• Get baseline IGF-1 and GH labs. Stimulating already-adequate GH is not benign.
• Use a licensed prescriber and regulated pharmacy, not a research chemical vendor.
• Understand that anecdotal two-week results on social media are confounded by approximately every variable imaginable: sleep, nutrition, training load, stress, menstrual cycle phase, and placebo response.
• Selank, which she also mentions, is a synthetic peptide with anxiolytic properties studied in Russian literature. The evidence base is limited and mostly preclinical or conducted in small Soviet-era trials with replication problems.

The mechanism behind CJC-1295 and ipamorelin is plausible. The jump from plausible mechanism to "glute growth I've never seen before in two weeks" is a large leap that no current controlled trial supports.